Zanamivir INN /zəˈnæmᵻvɪər/ is a neuraminidase inhibitor used in the
treatment and prophylaxis of influenza caused by influenza A and B viruses.
Zanamivir Oral Inhalation: learn about side effects, dosage, special precautions,
and more on MedlinePlus.
Name, Zanamivir. Accession Number, DB00558 (APRD00378). Type, Small
Molecule. Groups, Approved, Investigational. Description, A guanido-neuraminic
Jan 6, 2015 ... Learn about zanamivir (Relenza) a drug prescribed for the treatment of flu viruses
A and B (including H1N1 or swine flu). Side effects, drug ...
Zanamivir is an orally inhaled powder currently approved in 19 countries for the
treatment of, and in two for the prophylaxis of influenza A and B. Zanamivir is a ...
Zanamivir is a sialic acid-analogue neuraminidase inhibitor with antiviral activity.
Administered into the respiratory tract by aerosol inhalation, zanamivir ...
Find patient medical information for zanamivir inhalation on WebMD including its
uses, side effects and safety, interactions, pictures, warnings and user ratings.
Zanamivir is an antiviral injection that is used to prevent influenza. Often used
alongside other drugs such as oseltamivir. Read about zanamivir online at
Drug information on Relenza (zanamivir), includes drug pictures, side effects,
drug interactions, directions for use, symptoms of overdose, and what to avoid.
Dec 16, 2015 ... Relenza (zanamivir) is approved for treatment of acute uncomplicated illness due
to influenza A and B in patients 7 years of age and older.